Your browser doesn't support javascript.
loading
Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
Krug, David; Köder, Christine; Häfner, Matthias F; Arians, Nathalie; Harrabi, Semi B; Koerber, Stefan A; Forster, Tobias; Schlampp, Ingmar; Sohn, Christof; Heil, Joerg; Hof, Holger; Hörner-Rieber, Juliane; Debus, Jürgen.
Afiliación
  • Krug D; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. david.krug@uksh.de.
  • Köder C; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany. david.krug@uksh.de.
  • Häfner MF; Department of Radiation Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, 24105, Kiel, Germany. david.krug@uksh.de.
  • Arians N; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Harrabi SB; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
  • Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Forster T; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
  • Schlampp I; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Sohn C; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
  • Heil J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Hof H; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
  • Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Debus J; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Radiat Oncol ; 15(1): 235, 2020 Oct 13.
Article en En | MEDLINE | ID: mdl-33050920
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Radioterapia Conformacional / Reirradiación Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Radiat Oncol Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Radioterapia Conformacional / Reirradiación Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Radiat Oncol Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania